Evidence map›Paper›PMID 29155041›Full record

ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2018

Epidemiologic and Clinical Characteristics of Coronavirus and Bocavirus Respiratory Infections after Allogeneic Stem Cell Transplantation: A Prospective Single-Center Study.

José Luis Piñana, Silvia Madrid, Ariadna Pérez, Juan Carlos Hernández-Boluda, Estela Giménez, María José Terol, Marisa Calabuig, David Navarro, Carlos Solano

Registry-linked trialAbstract read
In one paragraph

Article in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04319172 (Multicentric Study of Coronavirus Disease 2019), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04319172 completednot on this mapstarted 2020, after this paper: background citation

Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients

TypeobservationalSponsorFundación Pública Andaluza para la gestión de la Investigación en SevillaRan2020 to 2023Enrolled488ConditionsTransplant Recipient, Infections, Coronavirus
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Role of Human Bocavirus Respiratory Tract Infection in Hematopoietic Cell Transplant Recipients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  7. Article
  8. Can COVID-19 cause severe neutropenia?Clinical case reports · 2020
    Article
  9. Review
  10. Use of whole-genome sequencing in the molecular investigation of care-associated HCoV-OC43 infections in a hematopoietic stem cell transplant unit.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2020
    Article
  11. Review
  12. Observational
  13. Review
  14. Review
  15. Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Observational
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

José Luis PiñanaDepartment of Hematology, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain; Department of Hematology, Hospital Universitari i Politècnic la Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid, Spain. Electronic address: jlpinana@gmail.com.
Silvia MadridMicrobiology Service, Hospital Clínico Universitario, Valencia, Spain.
Ariadna PérezDepartment of Hematology, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain.
Juan Carlos Hernández-BoludaDepartment of Hematology, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain.
Estela GiménezMicrobiology Service, Hospital Clínico Universitario, Valencia, Spain.
María José TerolDepartment of Hematology, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain.
Marisa CalabuigDepartment of Hematology, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain.
David NavarroMicrobiology Service, Hospital Clínico Universitario, Valencia, Spain; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
Carlos SolanoDepartment of Hematology, Hospital Clínico Universitario, Fundación INCLIVA, Valencia, Spain; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiologic data about coronaviruses (CoVs) and human bocavirus (HBoV) in the setting of allogeneic hematopoietic stem cell transplantation (allo-HSCT) are scarce. We conducted a prospective longitudinal study on respiratory viral infections (RVIs) in allo-HSCT recipients with respiratory symptoms from December 2013 until June 2016. Respiratory virus in upper and/or lower respiratory tract (URT and LRT) specimens were tested using Luminex xTAG RVP Fast v1 assay. Seventy-nine consecutive allo-HSCT recipients developed a total of 192 virologically documented RVI episodes over 30 months. The median follow-up after RVI was 388 days (range, 5 to 923). CoV or HBoV was detected in 27 of 192 episodes (14%); 18 of 79 recipients (23%) developed a total of 21 CoV RVI episodes, whereas 6 recipients (8%) had 1 HBoV RVI episode each. Fourteen CoV RVI episodes were limited to the URT, whereas 7 affected the LRT. Co-pathogens were detected in 8 (38%) CoV cases. Type OC43 CoV was the dominant type (48%) followed by NL63 (24%), KHU1 (19%), and 229E (9%); the CoV hospitalization rate was 19%, whereas mortality was 5% (1 patient without any other microbiologic documentation). Among the 6 recipients with HBoV (3%), only 1 had LRT involvement and no one died from respiratory failure. In 5 cases (83%) HBoV was detected along with other viral co-pathogens. CoV RVIs are common after allo-HSCT, and in a significant proportion of cases CoV progressed to LRT and showed moderate to severe clinical features. In contrast, HBoV RVIs were rare and mostly presented in the context of co-infections.

Indexed as

CoronavirusCoronavirus InfectionsHematopoietic Stem Cell TransplantationHospitalizationHuman bocavirusParvoviridae InfectionsRespiratory Tract InfectionsAdultAgedAllograftsFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesAllogeneic stem cell transplantationBocavirusCommunity-acquired respiratory virusCoronavirusRespiratory virus infectionViral pneumonia

Identifiers

PMID29155041
PMCPMC7110838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.